TY - JOUR
T1 - Anaplastic Kaposi's sarcoma
T2 - A study of eight patients
AU - Tourlaki, Athanasia
AU - Recalcati, Sebastiano
AU - Boneschi, Vinicio
AU - Gaiani, Francesca
AU - Colombo, Antonella
AU - Mancuso, Roberta
AU - Brambilla, Lucia
PY - 2013
Y1 - 2013
N2 - Anaplastic Kaposi's sarcoma is a rare form of vascular tumor, clinically notable for its high local aggressiveness, propensity for deep invasion and increased metastatic capacity. This cancer arises in patients with a history of Kaposi's sarcoma (KS) and because of its rarity, few clinical data are available. To gain insight into this rare disease, we present eight cases of anaplastic KS which developed in eight out of 578 (1.4%) patients suffering from classic KS and followed in our department over a period of 30 years. Clinically, seven patients presented with deep tissue invasion. All the anaplastic cases underwent systemic chemotherapy and five received a non-conservative surgical therapy. Four (50%) out of the eight patients are now in complete remission, while three (37.5%) of them died of anaplastic Kaposi's sarcoma and one (12.5%) died of pneumonia after an excellent response to chemotherapy alone. Our findings suggest that in patients with anaplastic KS, non-conservative surgery associated with systemic chemotherapy may lead to complete remission, avoiding the poor outcome reported in previous cases.
AB - Anaplastic Kaposi's sarcoma is a rare form of vascular tumor, clinically notable for its high local aggressiveness, propensity for deep invasion and increased metastatic capacity. This cancer arises in patients with a history of Kaposi's sarcoma (KS) and because of its rarity, few clinical data are available. To gain insight into this rare disease, we present eight cases of anaplastic KS which developed in eight out of 578 (1.4%) patients suffering from classic KS and followed in our department over a period of 30 years. Clinically, seven patients presented with deep tissue invasion. All the anaplastic cases underwent systemic chemotherapy and five received a non-conservative surgical therapy. Four (50%) out of the eight patients are now in complete remission, while three (37.5%) of them died of anaplastic Kaposi's sarcoma and one (12.5%) died of pneumonia after an excellent response to chemotherapy alone. Our findings suggest that in patients with anaplastic KS, non-conservative surgery associated with systemic chemotherapy may lead to complete remission, avoiding the poor outcome reported in previous cases.
KW - Anaplastic
KW - Chemotherapy
KW - Kaposi's sarcoma
KW - Lymphedema
KW - Prognosis
KW - Treatment
UR - http://www.scopus.com/inward/record.url?scp=84880613802&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84880613802&partnerID=8YFLogxK
U2 - 10.1684/ejd.2013.2019
DO - 10.1684/ejd.2013.2019
M3 - Article
C2 - 23783037
AN - SCOPUS:84880613802
SN - 1167-1122
VL - 23
SP - 382
EP - 386
JO - European Journal of Dermatology
JF - European Journal of Dermatology
IS - 3
ER -